Petros Efthimiou

3.0k total citations
56 papers, 2.0k citations indexed

About

Petros Efthimiou is a scholar working on Hematology, Rheumatology and Molecular Biology. According to data from OpenAlex, Petros Efthimiou has authored 56 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 21 papers in Rheumatology and 17 papers in Molecular Biology. Recurrent topics in Petros Efthimiou's work include Autoimmune and Inflammatory Disorders Research (22 papers), Inflammasome and immune disorders (11 papers) and Immune Cell Function and Interaction (9 papers). Petros Efthimiou is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (22 papers), Inflammasome and immune disorders (11 papers) and Immune Cell Function and Interaction (9 papers). Petros Efthimiou collaborates with scholars based in United States, Switzerland and Canada. Petros Efthimiou's co-authors include Sabeeda Kadavath, Apostolos Kontzias, Bella Mehta, L. J. Kagen, Sergio Schwartzman, David I. Shalowitz, Lara R. Gawenis, Lane L. Clarke, Daniel Mamah and Mark W. Musch and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and The Lancet Neurology.

In The Last Decade

Petros Efthimiou

52 papers receiving 2.0k citations

Peers

Petros Efthimiou

HEMAT

IMMUN

RHEUM

SURGE

Sonia Carta Italy

P. F. J. Ryan Australia

DirkJan Hijnen Netherlands

Samuel Katsuyuki Shinjo Brazil

Paola Galozzi Italy

John Highton New Zealand

Graeme J. Carroll Australia

Lidan Zhao China

Hedi Orbach Israel

Athan Baillet France

Sonia Carta Italy

Petros Efthimiou

487 ×0.5

HEMAT

1.0k ×1.2

IMMUN

179 ×0.3

RHEUM

1.5k ×2.5

241 ×0.7

SURGE

Citations per year, relative to Petros Efthimiou Petros Efthimiou (= 1×) peers Sonia Carta

Countries citing papers authored by Petros Efthimiou

Since Specialization

Citations

This map shows the geographic impact of Petros Efthimiou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petros Efthimiou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petros Efthimiou more than expected).

Fields of papers citing papers by Petros Efthimiou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petros Efthimiou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petros Efthimiou. The network helps show where Petros Efthimiou may publish in the future.

Co-authorship network of co-authors of Petros Efthimiou

This figure shows the co-authorship network connecting the top 25 collaborators of Petros Efthimiou. A scholar is included among the top collaborators of Petros Efthimiou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petros Efthimiou. Petros Efthimiou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Efthimiou, Petros, et al.. (2021). Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies. Seminars in Arthritis and Rheumatism. 51(4). 858–874. 86 indexed citations

Mehta, Bella, Said A. Ibrahim, William T. Briggs, & Petros Efthimiou. (2019). Racial/Ethnic variations in morbidity and mortality in Adult Onset Still's Disease: An analysis of national dataset. Seminars in Arthritis and Rheumatism. 49(3). 469–473. 36 indexed citations

Efthimiou, Petros, et al.. (2017). Tumor necrosis factor-associated periodic syndrome in adults. Rheumatology International. 38(1). 3–11. 3 indexed citations

Chao, Robert, et al.. (2017). Oxygen-Dependent Patient with Antisynthetase Syndrome Associated Interstitial Lung Disease Responds Promptly to Rituximab with Rapid Pulmonary Function Improvement. Mediterranean Journal of Rheumatology. 28(3). 153–156. 3 indexed citations

Bello, Alfonso E., et al.. (2017). Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis. Open Access Rheumatology Research and Reviews. Volume 9. 67–79. 81 indexed citations

Efthimiou, Petros, et al.. (2015). Impact of IL-1 inhibition on fatigue associated with autoinflammatory syndromes. Modern Rheumatology. 26(1). 3–8. 16 indexed citations

Kadavath, Sabeeda, et al.. (2015). Use of B lymphocyte stimulator inhibitor belimumab may be associated with a decrease in the serum concentration of epidermal growth factor in patients with primary Sjögren’s syndrome. Clinical Rheumatology. 34(9). 1651–1652. 2 indexed citations

Efthimiou, Petros, Sabeeda Kadavath, & Bella Mehta. (2014). Life-threatening complications of adult-onset Still’s disease. Clinical Rheumatology. 33(3). 305–314. 104 indexed citations

Kontzias, Apostolos & Petros Efthimiou. (2012). The Use of Canakinumab, a Novel IL-1β Long-Acting Inhibitor, in Refractory Adult-Onset Still's Disease. Seminars in Arthritis and Rheumatism. 42(2). 201–205. 69 indexed citations

10.

Efthimiou, Petros, et al.. (2009). Biological targets in the treatment of rheumatoid arthritis: a comprehensive review of current and in-development biological disease modifying anti-rheumatic drugs. SHILAP Revista de lepidopterología. 3 indexed citations

11.

Efthimiou, Petros, et al.. (2009). Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers. Modern Rheumatology. 19(5). 457–468. 59 indexed citations

12.

Efthimiou, Petros, et al.. (2009). Severe Adult-Onset Calcinosis in a Patient with a History of Juvenile Dermatomyositis: Figure 1.. The Journal of Rheumatology. 37(1). 194–194. 7 indexed citations

13.

Efthimiou, Petros, et al.. (2009). Complementary and alternative medicine use in rheumatoid arthritis: proposed mechanism of action and efficacy of commonly used modalities. Rheumatology International. 30(5). 571–586. 70 indexed citations

14.

Efthimiou, Petros, et al.. (2008). Intravenous Gammaglobulin and Thalidomide May Be an Effective Therapeutic Combination in Refractory Scleromyxedema: Case Report and Discussion of the Literature. Seminars in Arthritis and Rheumatism. 38(3). 188–194. 28 indexed citations

15.

Souayah, Nizar, et al.. (2008). Isolated severe vasculitic neuropathy revealing sarcoidosis. The Lancet Neurology. 7(8). 756–760. 4 indexed citations

16.

Efthimiou, Petros, et al.. (2007). Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?. Nature Clinical Practice Rheumatology. 3(6). 328–335. 61 indexed citations

17.

Efthimiou, Petros, et al.. (2006). Pathogenesis and Management of Adult-Onset Still’s Disease. Seminars in Arthritis and Rheumatism. 36(3). 144–152. 82 indexed citations

18.

Efthimiou, Petros. (2006). Tumor Necrosis Factor-α in Inflammatory Myopathies: Pathophysiology and Therapeutic Implications. Seminars in Arthritis and Rheumatism. 36(3). 168–172. 34 indexed citations

19.

Efthimiou, Petros & Joseph A. Markenson. (2005). Role of Biological Agents in Immune-mediated Inflammatory Diseases. Southern Medical Journal. 98(2). 192–204. 28 indexed citations

20.

Musch, Mark W., Lane L. Clarke, Daniel Mamah, et al.. (2002). T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+/K+-ATPase. Journal of Clinical Investigation. 110(11). 1739–1747. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact